About Daniel T. Kajunski

Daniel T. Kajunski is a lawyer practicing corporate & securities, venture capital & emerging companies, mergers & acquisitions and 8 other areas of law. Daniel received a B.A. degree from Saint Anselm College in 1994, and has been licensed for 28 years. Daniel practices at Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. in Boston, MA.

.show-short-text { max-height: unset !important;; } .hide-content-layer { display:none !important; }

Reviews for Daniel

This lawyer does not have any client reviews on Lawyers.com yet

Write a Review

Services

Areas of Law

Health Care
Other 10
- Corporate & Securities
- Venture Capital & Emerging Companies
- Mergers & Acquisitions
- Securities & Capital Markets
- Start-Ups
- Life Sciences
- Technology
- Communications & Media
- Financial Services
- Professional Services

Practice Details

Firm Information

Position
Member

Firm Name
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Representative Cases & Transactions

Cases
Representative Matters: Offerings for Public Companies: Represented Vertex Pharmaceuticals (Nasdaq: VRTX) in over $2.0 billion in equity
debt offerings since 2006
Represented ImmunoGen (Nasdaq: IMGN) in approximately $350 million in equity offerings since 2008
Represented Amedica (Nasdaq: AMDA) in its IPO
Represented the underwriters in the IPO of Calithera Biosciences (Nasdaq: CALA)
Represented the underwriters in the IPO of American Depositary Shares of GW Pharmaceuticals (Nasdaq: GWPH)
two additional follow-on offerings
Venture Capital & Strategic Financings: Represented a public technology company in the semiconductor
life sciences industry (Nasdaq) in multiple strategic investments
Represented a public medical device company (NYSE) in multiple strategic investments
Represented Clarus Ventures in its investments in Ophthotech (Nasdaq: OPHT), VBI Vaccines (Nasdaq: VBIV), TyRx Pharma,
Link Medicine
Represented a public biotechnology company (Nasdaq) in its strategic equity investment in a private biotechnology company
Represented Style Me Pretty in its strategic investment from AOL (NYSE: AOL)
Represented Synchroneuron in multiple equity financings
Represented TransMolecular in multiple equity
debt financings
Represented Ion Torrent Systems in multiple equity financings
Represented I-Pulse in multiple equity financings
Represented TransForm Pharmaceuticals in multiple equity financings
Represented Hemera Biosciences in its Series A financing
Mergers & Acquisitions: Represented a public biotechnology company (Nasdaq) in its entering into a merger option to acquire a private biotechnology company
Represented Clarus Ventures in the reverse merger of VBI Vaccines (Nasdaq: VBIV) with Paulson Capital
Represented Orchid BioSciences (Nasdaq: ORCH) in its sale to Laboratory Corporation of America (NYSE: LH)
Represented QIAGEN (Nasdaq: QGEN) in its purchase of SA Biosciences
Represented TransMolecular in its sale to Morphotek (a subsidiary of Eisai Co. (Tokyo Stock Exchange))
Represented Auspice in its sale to the ARRIS Group (Nasdaq: ARRS)
Represented EPIX Pharmaceuticals (Nasdaq: EPIX) in its merger with Predix Pharmaceuticals
Represented TransForm Pharmaceuticals in its sale to Johnson & Johnson (NYSE: JNJ)
Represented FastClick (Nasdaq: FSTC) in its sale to ValueClick (Nasdaq: VCLK)

.show-short-text { max-height: unset !important; } .hide-content-layer { display:none !important; }

Experience

Bar Admission & Memberships

Admissions
1998, Massachusetts
Education & Certifications

Law School
Suffolk University
Class of 1998
J.D.

Other Education
Saint Anselm College
Class of 1994
B.A.

.show-short-text { max-height: unset !important; } .hide-content-layer { display:none !important; }